Skip to content
Company Analysis

Sharps Technology Inc. STSS

A comprehensive view of key metrics, scores, and financial health for Sharps Technology Inc.

Overview of Sharps Technology, Inc.

STSS NCM
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Micro Cap
Sharps Technology, Inc. (STSS), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $1.12, about 0.0% overvalued vs fair value, -79.2% 1Y return, ranked 1063/1122 in sector.
USD 1.12
0.00%
(Delayed)
• Vol 90d: 79.0%
52-Week Range
Market Cap
$46.98M
Enterprise Value
$44.08M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 70%
Confidence: 82%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://sharpstechnology.com
HQ Melville, NY
Employees 55
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
Free Cash Flow
$-7.1M
23.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

FCF Conversion
76%
Fair

Free Cash Flow / Net Income — MedTech quality hallmark. ≥100% is typical and desirable; M&A amortisation makes GAAP NI lower than true cash earnings.

Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Sharps Technology Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
17
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
0
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 43% Coverage
Trade-Off Triangle Visualization A ternary plot showing STSS's balance between Growth (37.0%), Profitability (14.0%), and Safety (49.0%). Growth 37% Safety 49% Profitability 14%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

- vs peers
-
Key Signals
EPS Growth YoY 55.5% 72p Asset Growth YoY -38.0% 7p
Strengths
  • D/E Ratio in top 20% of peers (1.89, 90th percentile)
  • Debt/Assets in top 20% of peers (51.5%, 83th percentile)
  • Conservative leverage compared to industry peers
Risks
  • Growth axis has low metric coverage (25%) - score may be unreliable

Profitability

12th percentile vs peers
13
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

44th percentile vs peers
44
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Sharps Technology Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000